
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
Emira Bousoik, Hamidreza Montazeri Aliabadi
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 336
Emira Bousoik, Hamidreza Montazeri Aliabadi
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 336
Showing 1-25 of 336 citing articles:
A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors
Sukhvir Kaur, Yogita Bansal, Raj Kumar, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 5, pp. 115327-115327
Closed Access | Times Cited: 340
Sukhvir Kaur, Yogita Bansal, Raj Kumar, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 5, pp. 115327-115327
Closed Access | Times Cited: 340
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Jiang‐Jiang Qin, Yan Li, Jia Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 306
Jiang‐Jiang Qin, Yan Li, Jia Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 306
Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition
Hua Zhu, Zhihong Jian, Yi Zhong, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 222
Hua Zhu, Zhihong Jian, Yi Zhong, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 222
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Qian Ding, Wei Hu, Ran Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 203
Qian Ding, Wei Hu, Ran Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 203
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Paula Montero, Javier Milara, Inés Roger, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6211-6211
Open Access | Times Cited: 179
Paula Montero, Javier Milara, Inés Roger, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6211-6211
Open Access | Times Cited: 179
Transcription factors: Bridge between cell signaling and gene regulation
Paula Weidemüller, Maksim Kholmatov, Evangelia Petsalaki, et al.
PROTEOMICS (2021) Vol. 21, Iss. 23-24
Open Access | Times Cited: 162
Paula Weidemüller, Maksim Kholmatov, Evangelia Petsalaki, et al.
PROTEOMICS (2021) Vol. 21, Iss. 23-24
Open Access | Times Cited: 162
Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy
Sankhadip Bose, Sabyasachi Banerjee, Arijit Mondal, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1451-1451
Open Access | Times Cited: 160
Sankhadip Bose, Sabyasachi Banerjee, Arijit Mondal, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1451-1451
Open Access | Times Cited: 160
JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy
Sairaj Satarker, Antriya Annie Tom, Roshitha Ann Shaji, et al.
Postgraduate Medicine (2020) Vol. 133, Iss. 5, pp. 489-507
Open Access | Times Cited: 148
Sairaj Satarker, Antriya Annie Tom, Roshitha Ann Shaji, et al.
Postgraduate Medicine (2020) Vol. 133, Iss. 5, pp. 489-507
Open Access | Times Cited: 148
Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis
Moshe Talpaz, Jean‐Jacques Kiladjian
Leukemia (2020) Vol. 35, Iss. 1, pp. 1-17
Open Access | Times Cited: 143
Moshe Talpaz, Jean‐Jacques Kiladjian
Leukemia (2020) Vol. 35, Iss. 1, pp. 1-17
Open Access | Times Cited: 143
Transforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal Within
Abdul Basit Baba, Bilal Rah, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 131
Abdul Basit Baba, Bilal Rah, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 131
JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
Bilal Rah, Rafiq A. Rather, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 130
Bilal Rah, Rafiq A. Rather, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 130
Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation
Caleb R. Glassman, Naotaka Tsutsumi, Robert A. Saxton, et al.
Science (2022) Vol. 376, Iss. 6589, pp. 163-169
Open Access | Times Cited: 117
Caleb R. Glassman, Naotaka Tsutsumi, Robert A. Saxton, et al.
Science (2022) Vol. 376, Iss. 6589, pp. 163-169
Open Access | Times Cited: 117
Signaling pathways and targeted therapies for psoriasis
Jia Guo, H. Zhang, Wenrui Lin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 116
Jia Guo, H. Zhang, Wenrui Lin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 116
Identification and functional characterization of transcriptional activators in human cells
Nader Alerasool, He Leng, Zhen‐Yuan Lin, et al.
Molecular Cell (2022) Vol. 82, Iss. 3, pp. 677-695.e7
Open Access | Times Cited: 100
Nader Alerasool, He Leng, Zhen‐Yuan Lin, et al.
Molecular Cell (2022) Vol. 82, Iss. 3, pp. 677-695.e7
Open Access | Times Cited: 100
The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms
Jia Liu, Faping Wang, Fengming Luo
Biomolecules (2023) Vol. 13, Iss. 1, pp. 119-119
Open Access | Times Cited: 79
Jia Liu, Faping Wang, Fengming Luo
Biomolecules (2023) Vol. 13, Iss. 1, pp. 119-119
Open Access | Times Cited: 79
IL-6: The Link Between Inflammation, Immunity and Breast Cancer
Juan Chen, Yanghui Wei, Weiqin Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 71
Juan Chen, Yanghui Wei, Weiqin Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 71
JAK: Not Just Another Kinase
Ruchi Agashe, Scott M. Lippman, Razelle Kurzrock
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 12, pp. 1757-1764
Open Access | Times Cited: 70
Ruchi Agashe, Scott M. Lippman, Razelle Kurzrock
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 12, pp. 1757-1764
Open Access | Times Cited: 70
JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions
Alexey Sarapultsev, Evgeni Gusev, Maria Komelkova, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 52
Alexey Sarapultsev, Evgeni Gusev, Maria Komelkova, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 52
Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review
Tohada M. AL‐Noshokaty, Abdallah Mansour, Rehab Abdelhamid, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154438-154438
Closed Access | Times Cited: 51
Tohada M. AL‐Noshokaty, Abdallah Mansour, Rehab Abdelhamid, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154438-154438
Closed Access | Times Cited: 51
Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression
Lucas Fornari Laurindo, Jefferson Aparecido Dias, Adriano Cressoni Araújo, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 40
Lucas Fornari Laurindo, Jefferson Aparecido Dias, Adriano Cressoni Araújo, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 40
Astaxanthin anticancer effects are mediated through multiple molecular mechanisms: A systematic review
Immacolata Faraone, Chiara Sinisgalli, Angela Ostuni, et al.
Pharmacological Research (2020) Vol. 155, pp. 104689-104689
Open Access | Times Cited: 125
Immacolata Faraone, Chiara Sinisgalli, Angela Ostuni, et al.
Pharmacological Research (2020) Vol. 155, pp. 104689-104689
Open Access | Times Cited: 125
Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature
Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, Habbanakuppe D. Preetham, et al.
Seminars in Cancer Biology (2020) Vol. 80, pp. 157-182
Closed Access | Times Cited: 121
Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, Habbanakuppe D. Preetham, et al.
Seminars in Cancer Biology (2020) Vol. 80, pp. 157-182
Closed Access | Times Cited: 121
Matrine: A Promising Natural Product With Various Pharmacological Activities
Hong Zhang, Linlin Chen, Xipeng Sun, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 118
Hong Zhang, Linlin Chen, Xipeng Sun, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 118
The JAK/STAT Pathway in Skeletal Muscle Pathophysiology
Viviana Moresi, Sergio Adamo, Libera Berghella
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 110
Viviana Moresi, Sergio Adamo, Libera Berghella
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 110
Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins
Adriana Gutiérrez‐Hoya, Isabel Soto‐Cruz
Cells (2020) Vol. 9, Iss. 10, pp. 2297-2297
Open Access | Times Cited: 106
Adriana Gutiérrez‐Hoya, Isabel Soto‐Cruz
Cells (2020) Vol. 9, Iss. 10, pp. 2297-2297
Open Access | Times Cited: 106